With new data on petosemtamab set to be presented at the European Society for Medical Oncology Asia Congress, Merus believes ...

The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step ...

The following is a summary of “Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...

Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC– Conference call on ...